WHO: Smart needles are the key to preventing hepatitis B

Release date: 2015-03-17

201503132129288818.jpg

For the first time, the World Health Organization has published guidance on hepatitis B. The opinion pointed out that non-invasive testing should be used to monitor the condition. The treatment plan should include the use of Viread (tenofovir) and Baraclude (entecavir). Patients with cirrhosis should be treated preferentially.

The World Health Organization also emphasized the use of smart syringes to avoid the spread and spread of hepatitis B. Regarding this issue, WHO further explained that current treatment can prolong the life of patients, but it is equally important to prevent new infections.

A WHO spokeswoman told In-Pharmatechnologis.com: “The safely designed syringe is also known as the 'smart needle'. This syringe has a remarkable feature that it is very easy to avoid reuse. There is a completely different mechanism. The first mechanism is that after the injection is completed, a piece of metal will block the syringe so that the piston body cannot be pulled out again.” She added: “Another mechanism is to design a weak end at the end of the syringe. In the part, the syringe will be destroyed when the injection is completed. Other smart syringes also have needle protection characteristics - the plastic package covers the needle and the needle can be broken when the injection is completed."

save costs

A recent study pointed out that as many as 1.7 million hepatitis B patients and 310,000 HIV patients were infected with infected needles. In response to this result, WHO issued a warning about the danger of repeated use of the needle and gave this guidance a few weeks later.

According to the WHO, about 70 technology companies are developing such “smart needles” and it is recommended that national medical systems should give priority to this technology.

The biggest obstacle to this technology is its cost. According to the information available to WHO, the cost of “smart needles” is between US$0.03 and US$0.04, which is twice that of conventionally produced syringes.

The WHO's recommendation is that manufacturers of "smart needles" including Unilife, BD (former Becton, Dickinson and Company) BBraun, Terumo, Retractable Technologies RTIs, Medeco, SafeGard Medical should donate new technology to some health projects.

The idea behind this proposal is that these donations will increase demand and allow manufacturers to reduce production costs and lower prices.

The WHO spokeswoman stressed that preventing infection can reduce social costs. She explained: “A WHO survey on cost efficiency shows that every dollar invested in a safe injection program (including equipment procurement, personnel training, waste disposal) can save $14.”

Source: Bio-Exploration

USB Microscope

Usb Microscope,Digital Microscope Display Screen,Lcd Screen Digital Microscope,Digital Lcd Display Microscope

NINGBO VANCO INSTRUMENT CO.,LTD , https://www.vancoscope.com

Posted on